Inventor

ZAGURY DANIEL

FR23 patents

⚠️ This page may combine multiple inventors who share the name “ZAGURY DANIEL”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

ZAGURY DANIEL

NEOVACS

Inactive but immunogenic cytokines, pharmaceutical compositions containing same, and methods of treating homeostatic disorders associated with an overproduction of cytokines

Non-Toxic immunogens derived from a retroviral regulatory protein, antibodies, preparation method therefor, and pharmaceutical compositions containing same

Non-toxic immunogens derived from a retroviral regulatory protein antibodies preparation process and pharmaceutical compositions comprising them

Non-immunosuppressive immunogenic or vaccine composition comprising a mutated E7 protein of the HPV-16 virus

Chemically modified TNF-α

Immunogenic compounds with in particular an anti-cytokine effect, preparation process, pharmaceutical compositions and kits containing them

Method for preparing a stable immunogenic product comprising antigenic heterocomplexes of TNFα and a carrier protein

Use of inactive immunosuppressive and/or angiogenic immunogenic proteins, for producing secretory IgA&#39;s

Use of inactivated immunosuppressive or angiogenic immunogenic proteins for producing secretory IgA&#39;s

Method for preparing a stable TNF-α vaccine

Stable immunogenic product comprising antigenic heterocomplexes

Use of alicyclic diamines as immunomodulators

21C Bio

Vaccine to pathogenic immune activation cells during infections

Vaccine to pathogenic immune activation cells during infections

Vaccine to pathogenic immune activation cells during infections

Method of inhibiting HIV-1 viral rebound in a subject using interferon inhibitors and ART

NEOVACS S A

Chemically modified cytokines

Method for determining prognosis of HIV infected individuals

INST NAT SANTE RECH MED

Ex vivo generation of MHCII restricted CD4+ FOXP3+ regulatory T cells and therapeutic uses thereof

Ex vivo generation of γδ Foxp3+ regulatory T cells and therapeutic uses thereof

LE BUANNEC HELENE

Stable immunogenic product comprising antigenic heterocomplexes

BIZZINI BERNARD

High-yield method for the production of human antibodies blocking the biological activity of a human cytokine

ZAGURY JEAN FRANCOIS

Use of immunogens to treat or prevent, in malignant tumors, the immune or vascular disorders induced by extracellular factors

Use of inactive immunosuppressive and/or angiogenic immunogenic proteins, for producing secretory IgA's

Use of inactivated immunosuppressive or angiogenic immunogenic proteins for producing secretory IgA's